5 unknown, 4 completed, 1 enrolling by invitation, 1 recruiting. 2 Not applicable, 2 Phase 2, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Unknown 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Arteriosclerosis Obliterans: new trials by email Literature Review of Arteriosclerosis Obliterans trials Research Report on Arteriosclerosis Obliterans
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) NL003, Placebo - Peripheral Arterial Disease(PAD), Arterial Occlusive Disease | Enrolling by invitation | Beijing Northland Biotech. Co., Ltd. | 542 | 2025-06-30 | 2025-07-11 | |
| Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans open bypass group, bare metal stent group, plain old balloon angioplasty group - Arteriosclerosis Obliterans | Recruiting | First Affiliated Hospital, Sun Yat-Sen University | 400 | 2024-07-01 | 2026-09-10 | |
| Combined Treatment for Non-Healing Wounds in Chronic Lower Extremity Arterial Disease: A Comparative Study balloon angioplasty and stenting of lower extremity vessels + fibroblasts, balloon angioplasty and stenting of lower extremity vessels - Obliterans, Arteriosclerosis, Peripheral Arterial Disease | Not applicable | Completed | Tulip Medicine | 116 | 2023-01-09 | 2026-10-01 |
| A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans Alprostadil Liposomes for Injection, Alprostadil Injection - Arteriosclerosis Obliterans | Phase 2 | Unknown | Guangzhou Yipinhong Pharmaceutical CO.,LTD | 160 | 2016-08-01 | 2017-03-10 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia ADRC injection, ADRC isolation, Liposuction - Critical Limb Ischemia, Arteriosclerosis Obliterans | Phase 1 / Phase 2 | Unknown | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 9 | 2016-07-01 | 2016-08-12 |
| Arterial Calcification in the Diabetes serum RANKL - Diabetic Vascular Diseases, Arteriosclerosis Obliterans | Unknown | Assistance Publique - Hôpitaux de Paris | 169 | 2014-02-01 | 2018-06-04 | |
| HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) LDL-apheresis - Foot Ulcers, Arteriosclerosis Obliterans | Not applicable | Completed | Universita di Verona | 13 | 2012-02-01 | 2017-01-04 |
| Sufficient Treatment of Peripheral Intervention by Cilostazol cilostazol - Arteriosclerosis Obliterans | Phase 4 | Unknown | Kansai Rosai Hospital | 200 | 2009-03-01 | 2010-07-22 |
| Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker Cilostazol, Probucol, Cilostazol+Probucol - Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans | Phase 4 | Completed | Otsuka Beijing Research Institute | 200 | 2008-10-01 | 2025-03-27 |
| Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages Arteriosclerosis Obliterans | Completed | GE Healthcare | 103 | 2006-03-01 | 2011-04-28 | |
| TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation Autologous Bone Marrow Mononuclear Cell Implantation - Buerger Disease, Arteriosclerosis Obliterans | Unknown | Nagoya University | 2003-08-01 | 2005-12-30 |
Peripheral Arterial Disease (4) · Chronic Limb-Threatening Ischemia (3) · Diabetes Mellitus, Type 2 (3) · Diabetic Foot (3) · Thromboangiitis Obliterans (3) · Diabetes Mellitus (2) · Diabetic Angiopathies (2) · Arterial Occlusive Diseases (1) · Atherosclerosis (1) · Foot Ulcer (1) · Intermittent Claudication (1) · Monckeberg Medial Calcific Sclerosis (1)
Arteriosclerosis (11) · Cardiovascular Diseases (11) · Vascular Diseases (11) · Arterial Occlusive Diseases (10) · Endocrine System Diseases (6) · Peripheral Vascular Diseases (6) · Diabetes Complications (5) · Atherosclerosis (4) · Diabetes Mellitus (4) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Chronic Disease (3) · Diabetic Angiopathies (3)
Cilostazol (2) · Alprostadil (1) · Angioplasty, Balloon (1) · Control Groups (1) · Injections (1) · Lipectomy (1) · Probucol (1)
Assistance Publique - Hôpitaux de Paris (1) · Beijing Northland Biotech. Co., Ltd. (1) · Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · GE Healthcare (1) · Guangzhou Yipinhong Pharmaceutical CO.,LTD (1) · Kansai Rosai Hospital (1) · Nagoya University (1) · Otsuka Beijing Research Institute (1) · Tulip Medicine (1) · Universita di Verona (1)
China (4) · Japan (2) · Finland (1) · France (1) · Italy (1) · Kazakhstan (1) · Russia (1)
Andrey A Kalinin, MD, PhD (1) · Andrey A Pulin, MD, PhD (1) · Bonan Lv (1) · Dan Liu (1) · Enzo Bonora, MD, PhD (1) · Evgeny R Lysenko, MD, PhD, Prof (1) · Gang Zhao (1) · Haofu Wang (1) · Jichun Zhao (1) · Jun Zhao (1) · Maria Grazia Zenti, MD (1) · Olivier Bourron, MD, PhD (1) · Osamu Iida (1) · Qi Wang (1)
PMID 17251666, PMID 22700841, PMID 23652861, PMID 24558173, PMID 25544158, PMID 29706129, PMID 31168327, PMID 32948184, PMID 33377125, PMID 38351039, PMID 39984928, PMID 40269920